Education
About Us
Working with TipRanks
Follow Us
Castle Biosciences (CSTL)
NASDAQ:CSTL
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 332.07M | $ 219.79M | $ 137.04M | $ 94.08M | $ 62.65M |
| Gross Profit | $ 271.86M | $ 174.81M | $ 105.03M | $ 78.26M | $ 52.96M |
| Operating Income | $ 8.67M | $ -67.98M | $ -72.86M | $ -40.08M | $ -6.54M |
| EBITDA | $ 38.14M | $ -45.02M | $ -58.34M | $ -36.60M | $ -7.09M |
| Net Income | $ 18.25M | $ -57.47M | $ -67.14M | $ -31.29M | $ -10.28M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 293.13M | $ 243.10M | $ 258.63M | $ 329.63M | $ 409.85M |
| Total Assets | $ 531.24M | $ 453.34M | $ 447.33M | $ 462.57M | $ 439.33M |
| Total Debt | $ 26.34M | $ 15.34M | $ 13.40M | $ 8.20M | $ 0.00 |
| Net Debt | $ -93.36M | $ -83.51M | $ -109.55M | $ -321.43M | $ -409.85M |
| Total Liabilities | $ 75.40M | $ 62.07M | $ 48.18M | $ 50.83M | $ 23.64M |
| Stockholders' Equity | $ 455.83M | $ 391.27M | $ 399.15M | $ 411.74M | $ 415.69M |
| Cash Flow | |||||
| Free Cash Flow | $ 36.54M | $ -19.25M | $ -47.29M | $ -22.47M | $ 5.11M |
| Operating Cash Flow | $ 64.87M | $ -5.63M | $ -41.66M | $ -18.98M | $ 9.87M |
| Investing Cash Flow | $ -50.14M | $ -16.18M | $ -166.54M | $ -66.66M | $ -4.75M |
| Financing Cash Flow | $ 6.14M | $ -2.30M | $ 1.51M | $ 5.42M | $ 305.89M |